Phytocannabinoid-rich galenic preparations for topical administration: extraction and stability testing

Although medical cannabis was legalized in Czechia in 2013 and its use in topical treatments of skin disorders is now allowed, galenic formulations prepared from medical cannabis have not been widely implemented in the Czech healthcare system. One of the main reasons is the lack of a straightforward...

Full description

Bibliographic Details
Main Authors: Dominika Kaczorová, Jaroslav Peč, Tibor Béres, Nikola Štefelová, Sanja Ćavar Zeljković, Václav Trojan, Anežka Kosmáková Janatová, Pavel Klouček, Petr Tarkowski
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-08-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2023.1230728/full
_version_ 1797767114308714496
author Dominika Kaczorová
Dominika Kaczorová
Dominika Kaczorová
Jaroslav Peč
Tibor Béres
Nikola Štefelová
Sanja Ćavar Zeljković
Sanja Ćavar Zeljković
Václav Trojan
Anežka Kosmáková Janatová
Pavel Klouček
Petr Tarkowski
Petr Tarkowski
author_facet Dominika Kaczorová
Dominika Kaczorová
Dominika Kaczorová
Jaroslav Peč
Tibor Béres
Nikola Štefelová
Sanja Ćavar Zeljković
Sanja Ćavar Zeljković
Václav Trojan
Anežka Kosmáková Janatová
Pavel Klouček
Petr Tarkowski
Petr Tarkowski
author_sort Dominika Kaczorová
collection DOAJ
description Although medical cannabis was legalized in Czechia in 2013 and its use in topical treatments of skin disorders is now allowed, galenic formulations prepared from medical cannabis have not been widely implemented in the Czech healthcare system. One of the main reasons is the lack of a straightforward standardized protocol for their preparation. Cannabinoids, e.g., cannabidiol (CBD) and tetrahydrocannabinol (THC), have been shown to have therapeutic effects on various skin conditions, such as atopic dermatitis, psoriasis, scleroderma, acne and skin pigmentation. Recognizing the potential of dermatological treatment with medical cannabis, the present study aimed to evaluate the extraction capacity of various pharmaceutical bases for cannabinoids and the stability of prepared galenic formulations for dermatological applications with respect to cannabinoid content. The results showed that the stability of cannabinoids in formulations depended on the bases’ physical and chemical properties. The highest THC decomposition was observed in cream bases and Vaseline, with estimated percentage loss of total content of up to 5.4% and 5.6% per week, respectively. In contrast, CBD was more stable than THC. Overall, the tested bases were comparably effective in extracting cannabinoids from plant material. However, olive oil and Synderman bases exhibited the highest cannabinoid extraction efficiencies (approximately 70%) and the best storage stabilities in terms of the content of monitored compounds. The proposed preparation protocol is fast and easily implementable in pharmacies and medical facilities.
first_indexed 2024-03-12T20:35:06Z
format Article
id doaj.art-4ce4b5a48b29493b971c63fb101aa0b0
institution Directory Open Access Journal
issn 1663-9812
language English
last_indexed 2024-03-12T20:35:06Z
publishDate 2023-08-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pharmacology
spelling doaj.art-4ce4b5a48b29493b971c63fb101aa0b02023-08-01T13:34:33ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122023-08-011410.3389/fphar.2023.12307281230728Phytocannabinoid-rich galenic preparations for topical administration: extraction and stability testingDominika Kaczorová0Dominika Kaczorová1Dominika Kaczorová2Jaroslav Peč3Tibor Béres4Nikola Štefelová5Sanja Ćavar Zeljković6Sanja Ćavar Zeljković7Václav Trojan8Anežka Kosmáková Janatová9Pavel Klouček10Petr Tarkowski11Petr Tarkowski12Czech Advanced Technology and Research Institute, Palacký University, Olomouc, CzechiaDepartment of Genetic Resources for Vegetables, Medicinal and Special Plants, Centre of the Region Haná for Biotechnological and Agricultural Research, Crop Research Institute, Olomouc, CzechiaDepartment of Biochemistry, Faculty of Science, Palacký University, Olomouc, CzechiaPharm & Herb s. r. o, Prostějov, CzechiaCzech Advanced Technology and Research Institute, Palacký University, Olomouc, CzechiaCzech Advanced Technology and Research Institute, Palacký University, Olomouc, CzechiaCzech Advanced Technology and Research Institute, Palacký University, Olomouc, CzechiaDepartment of Genetic Resources for Vegetables, Medicinal and Special Plants, Centre of the Region Haná for Biotechnological and Agricultural Research, Crop Research Institute, Olomouc, CzechiaCannabis Facility, Centre for Translational Medicine, International Clinical Research Centre, St. Anne’s University Hospital, Brno, CzechiaDepartment of Food Science, Faculty of Agrobiology, Food and Natural Resources, Czech University of Life Sciences Prague, Prague, CzechiaDepartment of Food Science, Faculty of Agrobiology, Food and Natural Resources, Czech University of Life Sciences Prague, Prague, CzechiaCzech Advanced Technology and Research Institute, Palacký University, Olomouc, CzechiaDepartment of Genetic Resources for Vegetables, Medicinal and Special Plants, Centre of the Region Haná for Biotechnological and Agricultural Research, Crop Research Institute, Olomouc, CzechiaAlthough medical cannabis was legalized in Czechia in 2013 and its use in topical treatments of skin disorders is now allowed, galenic formulations prepared from medical cannabis have not been widely implemented in the Czech healthcare system. One of the main reasons is the lack of a straightforward standardized protocol for their preparation. Cannabinoids, e.g., cannabidiol (CBD) and tetrahydrocannabinol (THC), have been shown to have therapeutic effects on various skin conditions, such as atopic dermatitis, psoriasis, scleroderma, acne and skin pigmentation. Recognizing the potential of dermatological treatment with medical cannabis, the present study aimed to evaluate the extraction capacity of various pharmaceutical bases for cannabinoids and the stability of prepared galenic formulations for dermatological applications with respect to cannabinoid content. The results showed that the stability of cannabinoids in formulations depended on the bases’ physical and chemical properties. The highest THC decomposition was observed in cream bases and Vaseline, with estimated percentage loss of total content of up to 5.4% and 5.6% per week, respectively. In contrast, CBD was more stable than THC. Overall, the tested bases were comparably effective in extracting cannabinoids from plant material. However, olive oil and Synderman bases exhibited the highest cannabinoid extraction efficiencies (approximately 70%) and the best storage stabilities in terms of the content of monitored compounds. The proposed preparation protocol is fast and easily implementable in pharmacies and medical facilities.https://www.frontiersin.org/articles/10.3389/fphar.2023.1230728/fullCannabis sativa L.medical cannabisphytocannabinoidgalenic preparationextractstability
spellingShingle Dominika Kaczorová
Dominika Kaczorová
Dominika Kaczorová
Jaroslav Peč
Tibor Béres
Nikola Štefelová
Sanja Ćavar Zeljković
Sanja Ćavar Zeljković
Václav Trojan
Anežka Kosmáková Janatová
Pavel Klouček
Petr Tarkowski
Petr Tarkowski
Phytocannabinoid-rich galenic preparations for topical administration: extraction and stability testing
Frontiers in Pharmacology
Cannabis sativa L.
medical cannabis
phytocannabinoid
galenic preparation
extract
stability
title Phytocannabinoid-rich galenic preparations for topical administration: extraction and stability testing
title_full Phytocannabinoid-rich galenic preparations for topical administration: extraction and stability testing
title_fullStr Phytocannabinoid-rich galenic preparations for topical administration: extraction and stability testing
title_full_unstemmed Phytocannabinoid-rich galenic preparations for topical administration: extraction and stability testing
title_short Phytocannabinoid-rich galenic preparations for topical administration: extraction and stability testing
title_sort phytocannabinoid rich galenic preparations for topical administration extraction and stability testing
topic Cannabis sativa L.
medical cannabis
phytocannabinoid
galenic preparation
extract
stability
url https://www.frontiersin.org/articles/10.3389/fphar.2023.1230728/full
work_keys_str_mv AT dominikakaczorova phytocannabinoidrichgalenicpreparationsfortopicaladministrationextractionandstabilitytesting
AT dominikakaczorova phytocannabinoidrichgalenicpreparationsfortopicaladministrationextractionandstabilitytesting
AT dominikakaczorova phytocannabinoidrichgalenicpreparationsfortopicaladministrationextractionandstabilitytesting
AT jaroslavpec phytocannabinoidrichgalenicpreparationsfortopicaladministrationextractionandstabilitytesting
AT tiborberes phytocannabinoidrichgalenicpreparationsfortopicaladministrationextractionandstabilitytesting
AT nikolastefelova phytocannabinoidrichgalenicpreparationsfortopicaladministrationextractionandstabilitytesting
AT sanjacavarzeljkovic phytocannabinoidrichgalenicpreparationsfortopicaladministrationextractionandstabilitytesting
AT sanjacavarzeljkovic phytocannabinoidrichgalenicpreparationsfortopicaladministrationextractionandstabilitytesting
AT vaclavtrojan phytocannabinoidrichgalenicpreparationsfortopicaladministrationextractionandstabilitytesting
AT anezkakosmakovajanatova phytocannabinoidrichgalenicpreparationsfortopicaladministrationextractionandstabilitytesting
AT pavelkloucek phytocannabinoidrichgalenicpreparationsfortopicaladministrationextractionandstabilitytesting
AT petrtarkowski phytocannabinoidrichgalenicpreparationsfortopicaladministrationextractionandstabilitytesting
AT petrtarkowski phytocannabinoidrichgalenicpreparationsfortopicaladministrationextractionandstabilitytesting